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Dr Chumy Nwogu (Buffalo, NY). I enjoyed your presentation
much. I have a few questions. What was your incidence of spillage
of the ICG during the injection and what was the averagemigration
time that you encountered?
Dr Gilmore. The spillage was a problem early on. One of the
other Japanese groups that has done this actually uses an Endoclip
following injection. We have converted to a deeper injection of
about 1 cm of ICG in the later cohorts. While we do not have
the exact statistics, we have reduced the leakage rate.
As for the migration itself, we can clearly see on the video that
we see immediate identification of our injection site. We have
modified our technique so that now we do perform ventilation
for 1 to 2 minutes to increase the lymphatic flow and then follow-
ing deflation of the lung again we can see the migration.
Dr Nwogu.What do you think prevented migration in the cases
where you were unsuccessful?
Dr Gilmore. In unsuccessful cases early on, we feel that the
dose was too low at that point; this was based on preclinical trials.
Since we have now gone to higher doses, we feel we have more
consistent and reliable imaging, and, again, in the higher doses
this may be due to spillage.
Dr Nwogu. I wonder whether the ICG stops at the first echelon
of the sentinel node or does it go beyond that? What was the aver-
age number of lymph nodes you identified per patient?
Dr Gilmore. The average was one lymph node identified per
patient. There was only a total of 13 lymph nodes in 11 patients.
There were instances where there were 2 lymph nodes identified.
We do use ICG coupled with albumin, and we have seen this in-
creases retention within the first lymph node but does not permit
further migration.
Dr David Sugarbaker (Boston, Mass). I enjoyed your presen-
tation much, and I think this has a lot of potential. I have 2 ques-
tions. Number one, what is the interoperative time required from
initial injection to the identification of the sentinel node?
Dr Gilmore. It does not add a considerable amount of time to
the procedure itself. We do perform the injection and then ventilate
for 1 to 2 minutes to allow for increased migration. Following
deflation of the lung, we are then able to identify the lymph
node readily. And I think in total it may add an additional 10
to 15 minutes to the procedure.rdiovascular Surgery c Volume 146, Number 3 569
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SDr Sugarbaker. Actually I have 2 more questions real briefly.
Of interest, does the lung need to be inflated for optimal lymphatic
flow? You mentioned that. Is that a prerequisite or can you do it
with the lung atelectatic?
Dr Gilmore. We feel that ventilation of the lung does increase
lymphatic migration. In our earlier patients, we did use a deflated
lung, and we did not see as great a migration, and we feel that this
may be secondary to decreased lymphatic flow.
Dr Sugarbaker. And the third thing is one of the things that
concerns all of us in mapping our understanding an individual570 The Journal of Thoracic and Cardiovascular Surgpatient the lymphatic flow is crossover, particularly from lower
lobes to the contralateral 4R, so right lower lobe to 4R or right
lower lobe to 4L or left lower lobe to 4R as the first station. Do
you see in the future the ability to map both N2 and N3 stations
utilizing this technique?
Dr Gilmore. That is a good question. Currently, we do not have
that possibility, because during a normal video-assisted thoraco-
scopic surgery resection, we do not see the contralateral side,
but that is something we should consider.
Dr Sugarbaker. Thank you.ery c September 2013
